Erratum to "Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models"

Ya-Ya Yu; Yan-Juan Zhu; Ying Zou; Zhen-Zhen Xiao; Shuai Shi; Yi-Hong Liu; Xue-Song Chang; Ya-Dong Chen; Hai-Bo Zhang

doi:10.1155/2022/9808974

Erratum to "Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models"

Evid Based Complement Alternat Med. 2022 Mar 18:2022:9808974. doi: 10.1155/2022/9808974. eCollection 2022.

Authors

Ya-Ya Yu^{1

2}, Yan-Juan Zhu^{1

2

3

4}, Ying Zou^{1

5}, Zhen-Zhen Xiao^{1

2}, Shuai Shi^{1

6}, Yi-Hong Liu^{1

2}, Xue-Song Chang^{1

2}, Ya-Dong Chen^{1

2}, Hai-Bo Zhang^{1

2

3

4

7}

Affiliations

¹ Department of Oncology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
² Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
³ Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou, China.
⁴ Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.
⁵ Department of Integrated Traditional and Western Medicine, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
⁶ Department of Respiration Medicine, Luoyang First People's Hospital, Luoyang, Henan, China.
⁷ State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangzhou, China.

Abstract

[This corrects the article DOI: 10.1155/2021/9911935.].

Publication types

Published Erratum